Drug
PF 08653945
PF 08653945: highest development phase Phase 2, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| PF-08653945 NCT07575932 | Phase 2 | Overweight |
Latest
No recent events.
Follow PF 08653945 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.